Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (81-90 of 260) with videos related to

Pageof 26
Sort By:
Transplantation and Cellular Therapy|October 12, 2020
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023Nosha Farhadfar, Linda J Burns, Tatenda Mupfudze, et al.
JAMA Oncology|August 18, 2016
Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical TrialStephanie J Lee, Brent Logan, Peter Westervelt, et al.
Blood Reviews|April 22, 2023
How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?Mark Juckett, Christopher Dandoy, Zachariah DeFilipp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survivalMary Eapen, Brent R Logan, Dennis L Confer, et al.
Cancer|August 18, 2017
Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningfulBronwen E Shaw, Ruta Brazauskas, Heather R Millard, et al.
Cancer Investigation|August 29, 2002
Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory boardLisa A Bellm, Gail Cunningham, Laurie Durnell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2020
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease ProphylaxisMehdi Hamadani, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Eclinicalmedicine|September 18, 2024
Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort studyMary Eapen, Joseph H Antin, Jakub Tolar, et al.
Blood|February 24, 2007
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCTJeffery S Miller, Sarah Cooley, Peter Parham, et al.
American Journal of Hematology|October 17, 2022
Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102Rachel Cusatis, Michael J Martens, Ryotaro Nakamura, et al.
Pageof 26

Showing results (81-90 of 260) with videos related to

Sort By:
Pageof 26
Transplantation and Cellular Therapy|October 12, 2020
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023Nosha Farhadfar, Linda J Burns, Tatenda Mupfudze, et al.
JAMA Oncology|August 18, 2016
Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical TrialStephanie J Lee, Brent Logan, Peter Westervelt, et al.
Blood Reviews|April 22, 2023
How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?Mark Juckett, Christopher Dandoy, Zachariah DeFilipp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survivalMary Eapen, Brent R Logan, Dennis L Confer, et al.
Cancer|August 18, 2017
Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningfulBronwen E Shaw, Ruta Brazauskas, Heather R Millard, et al.
Cancer Investigation|August 29, 2002
Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory boardLisa A Bellm, Gail Cunningham, Laurie Durnell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2020
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease ProphylaxisMehdi Hamadani, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Eclinicalmedicine|September 18, 2024
Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort studyMary Eapen, Joseph H Antin, Jakub Tolar, et al.
Blood|February 24, 2007
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCTJeffery S Miller, Sarah Cooley, Peter Parham, et al.
American Journal of Hematology|October 17, 2022
Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102Rachel Cusatis, Michael J Martens, Ryotaro Nakamura, et al.
Pageof 26